Susquehanna Fundamental Investments’s Edwards Lifesciences EW Stock Holding History

Susquehanna Fundamental Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-55,864	Closed	-$4.34M	–	611
2025 Q3	$4.34M	Sell	55,864 -150,857	-73%	-$11.8M	0.17%	152
2025 Q2	$16.2M	Sell	206,721 -45,974	-18%	-$3.43M	0.44%	65
2025 Q1	$18.3M	Sell	252,695 -205,832	-45%	-$14.7M	0.26%	89
2024 Q4	$33.9M	Buy	+458,527	New	+$32.1M	0.49%	27
2021 Q2	–	Sell	-33,841	Closed	-$2.83M	–	1686
2021 Q1	$2.83M	Sell	33,841 -51,378	-60%	-$4.34M	0.05%	517
2020 Q4	$7.78M	Buy	+85,219	New	+$7.07M	0.14%	196

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Susquehanna Fundamental Investments's EW Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 55,864 shares — an estimated $4.34M sold.

Susquehanna Fundamental Investments first reported a position in EW in Q4 2020 and held it in 6 quarters. The position peaked at $33.9M in Q4 2024. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Susquehanna Fundamental Investments reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 55,864 Edwards Lifesciences shares in Q4 2025, an estimated $4.34M.
Susquehanna Fundamental Investments first reported a position in Edwards Lifesciences in Q4 2020 and held it in 6 quarters.
Susquehanna Fundamental Investments's Edwards Lifesciences position peaked at $33.9M in Q4 2024.
1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.